VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/06/12	06:17	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/12	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/06/03	05:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/30	05:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/26	20:14	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/26	20:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/26	20:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Virtual 2020 Stockholder Meeting	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/21	06:20	PR Newswire (US)	Vanda Pharmaceuticals Wins Motion To Dismiss False Claims Act Lawsuit	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/20	23:45	PR Newswire (US)	Vanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and Remdesivir	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/13	20:44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/13	20:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ® for the Treatment of Pati...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/07	20:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/07	05:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/05/07	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2020 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/30	05:05	PR Newswire (US)	Vanda Pharmaceuticals to Announce First Quarter 2020 Financial Results on May 6, 2020	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/25	05:43	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/23	05:07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/23	05:06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/16	05:15	PR Newswire (US)	Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Coll...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/16	05:05	PR Newswire (US)	Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/09	05:05	PR Newswire (US)	Vanda Pharmaceuticals Inc. And The University of Illinois at Chicago Announce Partnership To Identify Novel Antivirals Agains...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/04/03	02:37	PR Newswire (US)	Vanda Pharmaceuticals Announces the Initiation of ODYSSEY, an FDA Approved Clinical Study of Tradipitant in Hospitalized Pati...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/25	05:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/14	06:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/05	07:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/05	07:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/05	07:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/05	07:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/05	07:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/03/04	06:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc